P2.06-07 Genomic Deletion of BAP1 and CDKN2A Are Better MM Diagnostic Biomarkers.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Deletion of PTPRD and Cdkn2a Cooperate to Accelerate Tumorigenesis

Oncotarget
Oncology
2014English

Loss of P16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated With Worse Outcome and Younger Age in Thymic Carcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P2.06-41 Differentiating Sarcomatoid Mesothelioma From Pleomorphic Carcinoma and Chest Wall Sarcoma Using GATA-3/MUC4/BAP1 IHC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Two Paradigms Are Better Than One, and Multiple Paradigms Are Even Better

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2009English

Systems Biology and the Discovery of Diagnostic Biomarkers

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2010English

Diagnostic Biomarkers for Oral and Periodontal Diseases

Dental Clinics of North America
Dentistry
2005English

If Two Are Better Than One Three Are Better Than Two

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

The Arabidopsis BAP1 and BAP2 Genes Are General Inhibitors of Programmed Cell Death

Plant Physiology
Plant ScienceGeneticsPhysiology
2007English

For Better Utilization of Pathologic Diagnostic Procedures.

Journal of Japan Veterinary Cancer Society
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy